Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Rowe

Showing results (191-200 of 365) with videos related to

Pageof 37
Sort By:
Plos One|January 30, 2014
Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer's disease: a preliminary studyYen Ying Lim, Victor L Villemagne, Simon M Laws, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 19, 2010
In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133Nobuyuki Okamura, Victor L Villemagne, John Drago, et al.
Aging Brain|August 12, 2025
Sex differences in the association between episodic memory residual reserve index and change in executive functionCheyenne Chooi, Brandon E Gavett, David Ames, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 31, 2013
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 21, 2025
Combining Lumipulse p-tau217 and Aβ42/40 as confirmatory tests for Aβ positivity prior to disease-modifying therapyJames D Doecke, Ahmed Chenna, Mintzu Lo, et al.
Acta Neuropathologica|October 24, 2024
Autoantibodies to BACE1 promote Aβ accumulation and neurodegeneration in Alzheimer's diseaseYe-Ran Wang, Xiao-Qin Zeng, Jun Wang, et al.
Brain : a Journal of Neurology|August 27, 2010
Larger temporal volume in elderly with high versus low beta-amyloid depositionGaël Chételat, Victor L Villemagne, Kerryn E Pike, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 7, 2010
Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's diseaseVictor L Villemagne, Keyla A Perez, Kerryn E Pike, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|December 4, 2014
Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCIYen Ying Lim, Robert H Pietrzak, Pierrick Bourgeat, et al.
Neuroimage|August 2, 2022
β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3Pierrick Bourgeat, Vincent Doré, Samantha C Burnham, et al.
Pageof 37

Showing results (191-200 of 365) with videos related to

Sort By:
Pageof 37
Plos One|January 30, 2014
Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer's disease: a preliminary studyYen Ying Lim, Victor L Villemagne, Simon M Laws, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 19, 2010
In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133Nobuyuki Okamura, Victor L Villemagne, John Drago, et al.
Aging Brain|August 12, 2025
Sex differences in the association between episodic memory residual reserve index and change in executive functionCheyenne Chooi, Brandon E Gavett, David Ames, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 31, 2013
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 21, 2025
Combining Lumipulse p-tau217 and Aβ42/40 as confirmatory tests for Aβ positivity prior to disease-modifying therapyJames D Doecke, Ahmed Chenna, Mintzu Lo, et al.
Acta Neuropathologica|October 24, 2024
Autoantibodies to BACE1 promote Aβ accumulation and neurodegeneration in Alzheimer's diseaseYe-Ran Wang, Xiao-Qin Zeng, Jun Wang, et al.
Brain : a Journal of Neurology|August 27, 2010
Larger temporal volume in elderly with high versus low beta-amyloid depositionGaël Chételat, Victor L Villemagne, Kerryn E Pike, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 7, 2010
Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's diseaseVictor L Villemagne, Keyla A Perez, Kerryn E Pike, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|December 4, 2014
Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCIYen Ying Lim, Robert H Pietrzak, Pierrick Bourgeat, et al.
Neuroimage|August 2, 2022
β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3Pierrick Bourgeat, Vincent Doré, Samantha C Burnham, et al.
Pageof 37